|05 September, 2019

MSD recognized as a Great Place to Work highlighting commitment to employees

This prestigious recognition is a direct result of MSD's initiatives to create and sustain a diverse and vibrant workplace

MSD recognized as a Great Place to Work highlighting commitment to employees

MSD, a leading global pharmaceutical company, is proud to announce it has been certified as a Great Place to Work® after a thorough and independent analysis conducted by Great Place to Work® Institute, United Arab Emirates. This prestigious recognition is a direct result of MSD’s initiatives to create and sustain a diverse and vibrant workplace. 

Great Place to Work® is the global authority on workplace culture, employee experience and the leadership behaviors proven to deliver market-leading revenue and increased innovation. This certification was based on direct, validated feedback from MSD employees, provided as part of an extensive and anonymous survey about the workplace experience. 

The 2019 results of the independent assessment demonstrate MSD’s commitment to cultivating a strong culture within the workplace. In comparison with other companies in the local market, the MSD survey found high levels of pride, communication, a caring and collaborative approach to employees and a high level of integrity and justice. MSD’s HR practices and employee-driven initiatives have allowed the company to foster a diverse, inclusive workplace aligned with organizational missions and values. 

The strong results may be a direct result of the company’s diversity and inclusion initiatives. Regionally, MSD attracts a high caliber of employees from around the world and has a high female representation which is growing year-on-year, as the company is continually striving to become even more diverse. The company is also proud to have a strong millennial workforce that brings new ways of working and achieving success.

“We are thrilled to announce our employees have named MSD UAE a Great Place to Work® as a true reflection of our commitment to our people. Our employees are our most valuable resource and work daily to fulfil our mission to help improve health around the world. We are constantly seeking to make our workplace an environment which allows our employees demonstrate and develop their talents, in which they feel their skills and creativity are valued, where they feel engaged everyday doing their work” said Mazen Altaruti, AVP Managing Director GCC at MSD.

“We have worked long and hard to create a vibrant, people-centric culture among our employees, so this award is confirmation our ongoing efforts are paying off. We ensure a diverse workforce, with fair representation as our differences are our source of strength that allow us to appreciate nuances, develop respect, and ensure stronger business results” continued Altaruti. “We are committed to creating a productive environment and a unique company culture where employees contribute, grow and flourish on our journey to deliver excellence to our customers and patients. Above all, we aspire to have a great impact on the field of medicine, but this can only be done by harnessing the power of our workforce”. 

-Ends-

About MSD 

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. MSD products has been present for over 30 years in the GULF region through its local distributors in the UAE, Kuwait, Bahrain, Qatar & Oman and MSD ranks amongst the leading pharmaceutical companies in the region. MSD provides innovative medications in several therapeutic areas, including Anti-infectives, Cardiovascular, Asthma & Allergy, Diabetes, HCV, HIV, Pain & Inflammation, Osteoporosis, Oncology, Fertility, Ophthalmic, and Anesthesia in addition to several specialized Vaccines. 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases